+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

U.S. POC/Point-of-Care Coagulation Testing Market, 2019-2023: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics,

  • ID: 4807551
  • Report
  • Region: United States
  • 418 pages
  • VPG Market Research
1 of 2

FEATURED COMPANIES

  • Abbott
  • Bio/Data
  • Decode Genetics
  • Fujirebio
  • Leica Biosystems
  • SDIX
  • MORE
This new 418-page report from the author contains 42 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.

Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis
  • Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
  • Five-year test volume and reagent sales forecasts for coagulation procedures by market segment.
Sales and Market Share Analysis
  • Sales and market shares of major coagulation reagent and instrument suppliers.
Current and Emerging Products
  • Analysis of coagulation procedures performed in POC testing locations
  • Review of leading coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
Technology Review
  • Emerging technologies and their applications for POC testing
  • Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.
Competitive Assessments
  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
  • Specific opportunities for new coagulation instruments and reagent systems with potentially significant market appeal during the next five years
  • Design criteria for POC testing products
  • Alternative business expansion strategies
  • Potential market entry barriers and risks.
Methodology
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and the author's proprietary data files.
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
  • Abbott
  • Accriva
  • Agilent Technologies
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Chrono-Log
  • Corgenix
  • Decode Genetics
  • Diagnostica Stago
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • EKF Diagnostics
  • Fujirebio
  • Grifols
  • Helena Laboratories
  • Hologic
  • Horiba
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Leica Biosystems
  • Lonza
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sekisui Diagnostics
  • Sequenom
  • Siemens Healthineers
  • Sienco
  • Sysmex
  • Takara Bio
  • Thermo Fisher
  • Tosoh
  • Wako
Note: Product cover images may vary from those shown
Adroll
adroll